NIH-funded research R01 grant

Investigating how genetic changes in RNA modifications affect immune diseases

Official title: Genetic variation of N6-methyladenosine (m6A) RNA modification in immune cells and its contribution to human diseases

Funded at University of Chicago · NIH-10999470 · Data updated 2026-11-12

This study is looking at how certain genetic differences affect immune cells and may play a role in diseases like asthma and Alzheimer's, with the hope of finding new ways to improve treatments based on your unique genetics.

Quick facts

Grant typeR01 grant
Study typeNIH-funded research
Funding institutionUniversity of Chicago
NIH-funded
Lab location1 site (Chicago, United States)
Project startDecember 11, 2023
Project endOctober 31, 2028
Funding year2025
Award (this year)$755,042
NIH project number5R01AI175554-02
Project IDNIH-10999470 on NIH RePORTER

Who could benefit from this research

Could help

Ideal candidates for this research include individuals with immune-related conditions such as asthma or Alzheimer's disease.

Less likely to help

Patients with non-immune-related conditions or those without genetic variations affecting RNA modifications may not benefit from this research.

What this research studies

This research focuses on understanding how genetic variations in N6-methyladenosine (m6A) RNA modifications influence immune cell functions and contribute to diseases like asthma and Alzheimer's. By utilizing genome-wide association studies (GWAS), the project aims to identify risk variants and genes associated with immune disorders. The researchers will explore the role of m6A modifications in RNA processing, which may reveal new therapeutic targets for these conditions. Patients may benefit from insights that could lead to improved treatments based on their genetic profiles.

Why it matters

Potential benefit: If successful, this research could lead to new therapeutic strategies for immune-related diseases by identifying genetic factors that influence disease risk.

How similar studies have gone: Previous research has successfully identified genetic variants associated with immune diseases, suggesting that this approach has the potential for meaningful discoveries.

Where this research is happening

  • University of Chicago
    Chicago, United States
    Active

Researchers

  • Principal investigator: He, Xin — University of Chicago
  • Study coordinator: He, Xin

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.